GlassScriptPhysician profile
Chantal James Ashi
NPI 1659878403
$853.61
in general payments reported to CMS, 2019-2025
16 companies · $467 in 2025
The $467 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $386 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $196.08 | 2024-2025 | Veozah |
| Gynesonics, INC. | $145.67 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $116.48 | 2025 | Thinprep 2000 Processor, Myosure Tissue Removal Device, Novasure |
| Integra Lifesciences Corporation | $75.00 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Exeltis, USA INC. | $42.28 | 2024-2025 | Slynd |
| Millicent US INC | $40.35 | 2024-2025 | Femring, Intrarosa |
| Sumitomo Pharma America, INC. | $40.18 | 2024-2025 | Myfembree |
| Sage Therapeutics, LLC | $38.87 | 2025 | Zurzuvae |
| Davol INC. | $25.94 | 2025 | Arista |
| Mimedx Group, INC. | $24.49 | 2024 | |
| Pfizer INC. | $22.25 | 2025 | |
| Mayne Pharma Commercial LLC | $19.29 | 2024 | |
| Supernus Pharmaceuticals, INC. | $19.08 | 2025 | Qelbree |
| Organon LLC | $17.67 | 2025 | Nexplanon |
| Molnlycke Health Care US, LLC | $16.22 | 2025 | Mepilex Border Post-Op Ag |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $13.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chantal Ashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.